Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
![](/was/20151211033644im_/https://stanfordhealthcare.org/content/dam/SHC/doctors-medicalstaff/b/buckwalter-marion-md.jpg/_jcr_content/renditions/cq5dam.thumbnail.319.319.png.transform/221x221/q82/image.png)
Marion S. Buckwalter, MD, PhD
Neurocritical care specialist
Practice Areas
Professional Education
- Board Certification: Neurocritical Care, United Council for Neurologic Subspecialties (2008)
- Internship: Univ of California San Francisco (1997) CA
- Fellowship: UCSF Medical Center (2002) CA
- Residency: UCSF Medical Center (2000) CA
- Board Certification, United Council for Neurologic Subspecialties, Neurocritical Care (2008)
- Board Certification: Neurology, American Board of Psychiatry and Neurology (2001)
- Medical Education: University of Michigan School of Medicine (1996) MI
- MD PhD, University of Michigan, Human Genetics (1996)
- Internship, UCSF, Medicine (1997)
- Residency, UCSF, Neurology (2000)
- Fellowship, UCSF, Neurological Critical Care (2002)
Publications
-
Albumin induces excitatory synaptogenesis through astrocytic TGF-beta/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction
Weissberg, I., Wood, L., Kamintsky, L., Vazquez, O., Milikovsky, D. Z., & Kaufer, D. (2015). Albumin induces excitatory synaptogenesis through astrocytic TGF-beta/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction. NEUROBIOLOGY OF DISEASE, 78, 115-125. -
Metronidazole-Induced Encephalopathy: Not Always a Reversible Situation
Hobbs, K., Stern-Nezer, S., Buckwalter, M. S., Fischbein, N., & Caulfield, A. F. (2015). Metronidazole-Induced Encephalopathy: Not Always a Reversible Situation. NEUROCRITICAL CARE, 22(3), 429-436. -
B-Lymphocyte-Mediated Delayed Cognitive Impairment following Stroke
Doyle, K. P., Quach, L. N., Sole, M., Axtell, R. C., Nguyen, T.-V. V., & Buckwalter, M. S. (2015). B-Lymphocyte-Mediated Delayed Cognitive Impairment following Stroke. JOURNAL OF NEUROSCIENCE, 35(5), 2133-2145. -
Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice
Doyle, K. P., Quach, L. N., Arceuil, H. Ed., & Buckwalter, M. S. (2015). Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice. NEUROSCIENCE LETTERS, 584, 236-240.
-
Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice.
Cekanaviciute, E., Fathali, N., Doyle, K. P., Williams, A. M., Han, J., & Buckwalter, M. S. (2014). Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice. Glia, 62(8), 1227-1240.
-
Astrocytic TGF-ß signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection.
Cekanaviciute, E., Dietrich, H. K., Axtell, R. C., Williams, A. M., Egusquiza, R., & Buckwalter, M. S. (2014). Astrocytic TGF-ß signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. Journal of immunology , 193(1), 139-149.
-
A mouse model of permanent focal ischemia: distal middle cerebral artery occlusion.
Doyle, K. P., & Buckwalter, M. S. (2014). A mouse model of permanent focal ischemia: distal middle cerebral artery occlusion. Methods in molecular biology (Clifton, N.J.), 1135, 103-110.
-
Chronic Over-Expression of TGF beta 1 Alters Hippocampal Structure and Causes Learning Deficits
Martinez-Canabal, A., Wheeler, A. L., Sarkis, D., Lerch, J. P., Lu, W.-Y., & Frankland, P. W. (2013). Chronic Over-Expression of TGF beta 1 Alters Hippocampal Structure and Causes Learning Deficits. HIPPOCAMPUS, 23(12), 1198-1211.
-
Suppression of Inflammation with Conditional Deletion of the Prostaglandin E-2 EP2 Receptor in Macrophages and Brain Microglia
Johansson, J. U., Pradhan, S., Lokteva, L. A., Woodling, N. S., Ko, N., & Andreasson, K. I. (2013). Suppression of Inflammation with Conditional Deletion of the Prostaglandin E-2 EP2 Receptor in Macrophages and Brain Microglia. JOURNAL OF NEUROSCIENCE, 33(40), 16016-16032.
-
Serum Neuron-Specific Enolase Levels from the Same Patients Differ Between Laboratories: Assessment of a Prospective Post-cardiac Arrest Cohort
Mlynash, M., Buckwalter, M. S., Okada, A., Caulfield, A. F., Venkatasubramanian, C., & Wijman, C. Ac. (2013). Serum Neuron-Specific Enolase Levels from the Same Patients Differ Between Laboratories: Assessment of a Prospective Post-cardiac Arrest Cohort. NEUROCRITICAL CARE, 19(2), 161-166.
-
A small molecule p75(NTR) ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model
Knowles, J. K., Simmons, D. A., Nguyen, T.-V. V., Vander Griend, L., Xie, Y., & Longo, F. M. (2013). A small molecule p75(NTR) ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model. NEUROBIOLOGY OF AGING, 34(8), 2052-2063.
-
Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis
Kim, S. Y., Buckwalter, M., Soreq, H., Vezzani, A., & Kaufer, D. (2012). Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis. EPILEPSIA, 53, 37-44.
-
Stratification substantially reduces behavioral variability in the hypoxic-ischemic stroke model
Pollak, J., Doyle, K. P., Mamer, L., Shamloo, M., & Buckwalter, M. S. (2012). Stratification substantially reduces behavioral variability in the hypoxic-ischemic stroke model. BRAIN AND BEHAVIOR, 2(5), 698-706.
-
Delayed Administration of a Small Molecule Tropomyosin-Related Kinase B Ligand Promotes Recovery After Hypoxic-Ischemic Stroke
Han, J., Pollak, J., Yang, T., Siddiqui, M. R., Doyle, K. P., & Buckwalter, M. S. (2012). Delayed Administration of a Small Molecule Tropomyosin-Related Kinase B Ligand Promotes Recovery After Hypoxic-Ischemic Stroke. STROKE, 43(7), 1918-1924.
-
The double-edged sword of inflammation after stroke: What sharpens each edge?
Doyle, K. P., & Buckwalter, M. S. (2012). The double-edged sword of inflammation after stroke: What sharpens each edge?. ANNALS OF NEUROLOGY, 71(6), 729-731.
-
Distal hypoxic stroke: A new mouse model of stroke with high throughput, low variability and a quantifiable functional deficit
Doyle, K. P., Fathali, N., Siddiqui, M. R., & Buckwalter, M. S. (2012). Distal hypoxic stroke: A new mouse model of stroke with high throughput, low variability and a quantifiable functional deficit. JOURNAL OF NEUROSCIENCE METHODS, 207(1), 31-40.
-
A comparison of cooling techniques to treat cardiac arrest patients with hypothermia.
Finley Caulfield, A., Rachabattula, S., Eyngorn, I., Hamilton, S. A., Kalimuthu, R., & Wijman, C. Ac. (2011). A comparison of cooling techniques to treat cardiac arrest patients with hypothermia. Stroke research and treatment, 2011, 690506-?.
-
TGF beta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke
Doyle, K. P., Cekanaviciute, E., Mamer, L. E., & Buckwalter, M. S. (2010). TGF beta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. JOURNAL OF NEUROINFLAMMATION, 7.
-
Outcome prediction in mechanically ventilated neurologic patients by junior neurointensivists
Caulfield, A. F., GABLER, L., Lansberg, M. G., Eyngorn, I., Mlynash, M., & Wijman, C. Ac. (2010). Outcome prediction in mechanically ventilated neurologic patients by junior neurointensivists. NEUROLOGY, 74(14), 1096-1101.
-
Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis
Luo, J., Ho, P. P., Buckwalter, M. S., Hsu, T., Lee, L. Y., & Wyss-Coray, T. (2007). Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. JOURNAL OF CLINICAL INVESTIGATION, 117(11), 3306-3315.
-
Increased T cell recruitment to the CNS after amyloid beta(1-42) immunization in Alzheimer's mice overproducing transforming growth factor-beta 1
Buckwalter, M. S., Coleman, B. S., Buttini, M., Barbour, R., Schenk, D., & Wyss-Coray, T. (2006). Increased T cell recruitment to the CNS after amyloid beta(1-42) immunization in Alzheimer's mice overproducing transforming growth factor-beta 1. JOURNAL OF NEUROSCIENCE, 26(44), 11437-11441.
-
Chronically increased transforming growth factor-beta 1 strongly inhibits hippocampal neurogenesis in aged mice
Buckwalter, M. S., Yamane, M., Coleman, B. S., Ormerod, B. K., Chin, J. T., & Wyss-Coray, T. (2006). Chronically increased transforming growth factor-beta 1 strongly inhibits hippocampal neurogenesis in aged mice. AMERICAN JOURNAL OF PATHOLOGY, 169(1), 154-164.
-
Modelling neuroinflammatory phenotypes in vivo.
Buckwalter, M. S., & Wyss-Coray, T. (2004). Modelling neuroinflammatory phenotypes in vivo. Journal of neuroinflammation, 1(1), 10.
-
Modelling neuroinflammatory phenotypes in vivo
Buckwalter, M. S., & Wyss-Coray, T. (2004). Modelling neuroinflammatory phenotypes in vivo. JOURNAL OF NEUROINFLAMMATION, 1.
-
Molecular and functional dissection of TGF-beta 1-induced cerebrovascular abnormalities in transgenic mice
Buckwalter, M., Pepper, J. P., Gaertner, R. F., Von Euw, D., Lacombe, P., & Wyss-Coray, T. (2002). Molecular and functional dissection of TGF-beta 1-induced cerebrovascular abnormalities in transgenic mice. ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 977, 87-95.
-
Construction of a 3-Mb contig and partial transcript map of the central region of mouse chromosome 11
WATKINSCHOW, D. E., Douglas, K. R., Buckwalter, M. S., Probst, F. J., & Camper, S. A. (1997). Construction of a 3-Mb contig and partial transcript map of the central region of mouse chromosome 11. GENOMICS, 45(1), 147-157.
-
Genetic mapping of 21 genes on mouse chromosome 11 reveals disruptions in linkage conservation with human chromosome 5
WATKINSCHOW, D. E., Buckwalter, M. S., Newhouse, M. M., Lossie, A. C., Brinkmeier, M. L., & Camper, S. A. (1997). Genetic mapping of 21 genes on mouse chromosome 11 reveals disruptions in linkage conservation with human chromosome 5. GENOMICS, 40(1), 114-122.
-
A FRAMESHIFT MUTATION IN THE MOUSE ALPHA(1) GLYCINE RECEPTOR GENE (GLRA1) RESULTS IN PROGRESSIVE NEUROLOGICAL SYMPTOMS AND JUVENILE DEATH
Buckwalter, M. S., Cook, S. A., Davisson, M. T., White, W. F., & Camper, S. A. (1994). A FRAMESHIFT MUTATION IN THE MOUSE ALPHA(1) GLYCINE RECEPTOR GENE (GLRA1) RESULTS IN PROGRESSIVE NEUROLOGICAL SYMPTOMS AND JUVENILE DEATH. HUMAN MOLECULAR GENETICS, 3(11), 2025-2030.
-
A MISSENSE MUTATION IN THE GENE ENCODING THE ALPHA(1) SUBUNIT OF THE INHIBITORY GLYCINE RECEPTOR IN THE SPASMODIC MOUSE
Ryan, S. G., Buckwalter, M. S., LYNCH, J. W., Handford, C. A., Segura, L., & OCONNELL, P. (1994). A MISSENSE MUTATION IN THE GENE ENCODING THE ALPHA(1) SUBUNIT OF THE INHIBITORY GLYCINE RECEPTOR IN THE SPASMODIC MOUSE. NATURE GENETICS, 7(2), 131-135.
-
GENETIC-MAPPING AND EVALUATION OF CANDIDATE GENES FOR SPASMODIC, A NEUROLOGICAL MOUSE MUTATION WITH ABNORMAL STARTLE RESPONSE
Buckwalter, M. S., Testa, C. M., Noebels, J. L., & Camper, S. A. (1993). GENETIC-MAPPING AND EVALUATION OF CANDIDATE GENES FOR SPASMODIC, A NEUROLOGICAL MOUSE MUTATION WITH ABNORMAL STARTLE RESPONSE. GENOMICS, 17(2), 279-286.
-
LYSYL OXIDASE (LOX) MAPS BETWEEN GRL-1 AND ADRB-2 ON MOUSE CHROMOSOME-18
Lossie, A. C., Buckwalter, M. S., & Camper, S. A. (1993). LYSYL OXIDASE (LOX) MAPS BETWEEN GRL-1 AND ADRB-2 ON MOUSE CHROMOSOME-18. MAMMALIAN GENOME, 4(3), 177-178.
-
LOCALIZATION OF THE HUMAN CHROMOSOME-5Q GENES GABRA-1, GABRG-2, IL-4, IL-5, AND IRF-1 ON MOUSE CHROMOSOME-11
Buckwalter, M. S., Lossie, A. C., SCARLETT, L. M., & Camper, S. A. (1992). LOCALIZATION OF THE HUMAN CHROMOSOME-5Q GENES GABRA-1, GABRG-2, IL-4, IL-5, AND IRF-1 ON MOUSE CHROMOSOME-11. MAMMALIAN GENOME, 3(10), 604-607.
-
MOUSE CHROMOSOME-11
BUCHBERG, A. M., Buckwalter, M. S., & Camper, S. A. (1992). MOUSE CHROMOSOME-11. MAMMALIAN GENOME, 3, S162-S181.
-
LOCALIZATION OF THE PANHYPOPITUITARY DWARF MUTATION (DF) ON MOUSE CHROMOSOME-11 IN AN INTERSUBSPECIFIC BACKCROSS
Buckwalter, M. S., Katz, R. W., & Camper, S. A. (1991). LOCALIZATION OF THE PANHYPOPITUITARY DWARF MUTATION (DF) ON MOUSE CHROMOSOME-11 IN AN INTERSUBSPECIFIC BACKCROSS. GENOMICS, 10(3), 515-526.
-
Mouse chromosome 11.
BUCHBERG, A. M., Moskow, J. J., Buckwalter, M. S., & Camper, S. A. (1991). Mouse chromosome 11. Mammalian genome , 1, S158-91.
-
BACTERIOPHAGE-MU SITES REQUIRED FOR TRANSPOSITION IMMUNITY
Darzins, A., KENT, N. E., Buckwalter, M. S., & CASADABAN, M. J. (1988). BACTERIOPHAGE-MU SITES REQUIRED FOR TRANSPOSITION IMMUNITY. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 85(18), 6826-6830.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.